Acelrx Pharmaceuticals Inc

-0.06 (-5.50%)
7:16:18 PM EDT: $1.01 -0.02 (-1.94%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.63M
Current PE0.20
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.04 Million
Adjusted EPS-$0.51
See more estimates
10-Day MA$0.96
50-Day MA$0.75
200-Day MA$2.41
See more pivots

Acelrx Pharmaceuticals Inc Stock, NASDAQ:ACRX

25821 Industrial Boulevard, Suite 400, Hayward, California 94545
United States of America
Phone: +1.650.216.3500
Number of Employees: 19


AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Hayward, CA.